Streetbeat News

Products Services

AZN

DSKYF

DSNKY

AstraZeneca and Daiichi Sankyo announced that their partnered cancer drug, datopotamab deruxtecan (Dato-DXd), met its primary goal in a phase 3 trial for breast cancer. The drug showed a significant improvement in progression-free survival compared to chemotherapy. The safety profile was consistent with previous trials, and no new safety issues were identified. The overall survival data is still being assessed. AstraZeneca's shares rose 2.66% in premarket trading following the news.

Portfolio Pulse from Vandana Singh

September 22, 2023 | 11:46 am

BABA

JD

Chinese e-commerce sellers are using AI to generate 24/7 livestream commercials with deepfakes of influencers. Alibaba Group-owned Taobao and JD.com's JD Live have their own live-streaming platforms. Livestream shopping is expected to reach $720 billion by the end of 2023 in China. Silicon Intelligence, a company specializing in text-to-speech technology, is behind the livestream shopping boom. However, the use of AI clones is causing a decrease in the average salary of livestream hosts in China.

Portfolio Pulse from Rounak Jain

September 22, 2023 | 11:12 am

BMY

Bristol Myers Squibb's Phase 3 Checkmate -77T trial has met its primary endpoint of improved event-free survival in non-small cell lung cancer. The trial evaluated the use of neoadjuvant Opdivo (Nivolumab) with chemotherapy followed by surgery and adjuvant Opdivo.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 11:10 am

RNLX

Renalytix has expanded the insurance coverage of KidneyIntelX in Texas by securing contracts with BlueCross and BlueShield of Texas (BCBSTX) and Parkland Community Health Plan (PCHP). This complements coverage already secured with several other Blue Cross Blue Shield plans across the country. The company believes that achieving payer coverage with these large state-wide plans is crucial for bringing the benefits of KidneyIntelX prognostic technology to large populations of adults with type 2 diabetes and early stage kidney disease.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 11:10 am

ASLN

ASLAN Pharmaceuticals has announced that its late breaker abstract on Eblasakimab Phase 2b results will be presented orally at the 32nd European Academy of Dermatology and Venereology Congress. Additionally, three more abstracts from ASLAN will be presented at the congress.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 11:08 am

EDBL

Edible Garden has announced the launch of fall floral and ornamental shipments from its new facility in Grand Rapids, Michigan. The company, which is known for its sustainable and locally grown produce, is expanding its operations with this new facility.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 11:05 am

ESALF

MRK

Merck and Eisai's two Phase 3 trials evaluating Keytruda plus Lenvima in certain types of metastatic non-small cell lung cancer did not meet its dual primary endpoints of overall survival and progression-free survival.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 10:49 am

ZVSA

Zyversa Therapeutics has announced the publication of a paper in the Journal of Clinical Investigation, reinforcing the rationale for using IC 100 to inhibit ASC specks and attenuate the spread of inflammation into surrounding tissues.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 10:38 am

TSLA

Tesla Inc. is planning to expand its operations in India, focusing on enhancing the country's battery storage infrastructure. The company is in advanced talks to establish an EV factory in India and plans to introduce its Powerwall technology, a system designed to store power from solar panels or the grid. However, Tesla's pursuit of incentives for a battery storage factory has been met with hesitation from Indian officials. Despite this, the government is considering creating a business model that may extend subsidies to consumers of such products.

Portfolio Pulse from Shomik Sen Bhattacharjee

September 22, 2023 | 10:27 am

AAPL

Apple Inc. (NASDAQ:AAPL) has introduced Adaptive Audio, a new feature in its latest operating system, iOS 17. This feature, available to second-generation AirPods Pro users, dynamically adjusts noise control based on the user's surroundings and activities, enhancing the listening experience.

Portfolio Pulse from Ananya Gairola

September 22, 2023 | 10:22 am